Abstract
Benign prostatic hyperplasia (BPH) is emerging as a significant public health problem as the high prevalence of the disease is becoming increasingly recognised. In order to minimise the morbidity, mortality and economic burden from BPH it is important to delineate its causal factors so that appropriate intervention is undertaken where feasible. The aetiology of BPH is not fully understood, and additional research at biochemical, pathological, clinical and epidemiological levels is required. This chapter outlines the contribution of epidemiology to elucidating the aetiological factors known to date. It begins with a general discussion on risk factors and disease causation. This is followed by a review of the important methodological difficulties encountered in the investigation of BPH. Finally, the evidence for individual risk factors is presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldercreutz H (1988) Lignans and phytoestrogens. Possible preventive role in cancer. In: Rozen P, Hortwitz C (eds) Frontiers in gastrointestinal research. Karger, Basel, pp 165–176.
Anderson JT, Nordling J, Walter S (1979) Prostatism 1. The correlation between symptoms, cystometric and urodynamic findings. Scand J Urol Nephrol 13:229–236
Anderson KE, Kappas A (1982) Hormones and liver function. In: Schiff L, Schiff ER (eds) Diseases of the liver. Lippincott, Philadelphia, pp 167–236
Araki H, Watanabe H, Mishina T, Nakao H (1983) High-risk group for benign prostatic hypertrophy. Prostate 4:253–264
Armenian HK, Lilienfeld AM, Diamond EL, Bross IDJ (1975) Epidemiological characteristics of patients with prostatic neoplasms. Am J Epidemiol 102:47–54
Arrighi HM, Metter EJ, Guess HA, Fozzard JL (1991) Natural history of benign prostatic hyperplasia and risle of prostatectomy. Urology 38[Suppl]:4–8
Arrighi HM, Guess HA, Metter EJ, Fozzard JL (1990) Symptoms and signs of prostatism as risk factors for prostatectomy. Prostate 16:253–261
Ashley DJ (1966) Observations of the epidemiology of prostatic hyperplasia in Wales. Br J Urol 38:567–569
Ball AJ, Feneley RCL, Abrams PM (1981) The natural history of untreated prostatism. Br J Urol 53:613–616
Barnes BA, O’Brien E, Comstock C, D’Arpa DG, Donahue CL (1985) Report on variation in rates of utilization of surgical services in the commonwealth of Massachusetts. JAMA 254:371–375
Barnes RW, Marsh C (1983) Progression of obstruction and symptoms. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 711–713
Barrett-Connor E (1990) Smoking and endogenous sex hormones in men and women. In: Wald N, Baron J (eds) Smoking and hormone related disorders. Oxford University Press, Oxford, pp 183–196
Barrett-Connor E, Khaw K-T (1987) Cigarette smoking and increased endogenous estrogen levels in men. Am J Epidemiol 126:187–192
Barry MJ (1990) Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 17:495–507
Barry MJ, Boyle P, Garraway M et al (1993) Epidemiology and natural history of BPH. In: Cockett ATK, Khoury S, Aso Y et al (eds) Proceedings of the 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). WHO, Geneva, pp 19–28
Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479
Birkhoff JD, Wiederborn AR, Hamilton MC, Einssen HM (1976) Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 7:48–52
Bostwick DG, Sole Balcells F, Cooner WH et al (1992) Benign prostatic hyperplasia (BPH) and cancer of the prostate. In: Cockett ATK, Aso Y, Chatelain C et al (eds) Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH). WHO, Geneva, pp 139–159
Bourke JB, Griffin JP (1966) Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy. Br J Urol 38:18–23
Boyle P, McGinn R, Maisonneuve P, La Vecchia C (1991) Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur Urol 20[Suppl 2]:3–10
Bradford-Hill A (1965) The environment and disease: association or cause? Proc R Soc Med 58:295
Briggs MH (1973) Cigarette smoking and infertility in men. Med J Aust 1:616–617
Chang HL, Char GY (1936) Benign hypertrophy of the prostate. Chin Med J 50:1707–1722
Chopra IJ, Tulchinsky D, Greenway FL (1973) Estrogen-androgen imbalance in hepatic cirrhosis. Ann Intern Med 79:198–203
Chyou P-H, Nomura AMY, Stemmermann GN, Hankin JH (1993) A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 22:253–264
Clarke R (1937) The prostate and the endocrines. A control series. Br J Urol 9:254–271
Craigen AA, Hickling JB, Saunders CR, Carpenter RJ (1969) Natural history of prostatic obstruction. J R Coll Gen Pract 18:226–232
Dai WS, Gutai JP, Kuller LH, Cauley JA, for the MRFIT Research Group (1988) Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128:796–805
D’Aunoy R, Schenken JR, Burns EL (1939) The relative incidence of hyperplasia of the prostate in white and coloured races in Louisiana. South Med J 32:47–52
Danieli HW (1993) Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 149:315–317
de la Torre B, Hedman M, Jensen F, Pedersen PH, Diczfaluzy E (1983) Lack of effect of vasectomy on peripheral gonadotrophins and steroid levels. Int J Androl 6:125–134
Derbes VDP, Leche Sm, Hooker CW (1937) The incidence of benign prostatic hypertrophy amongst the whites and negroes in New Orleans. J Urol 38:383–388
Diokno AC, Brown MB, Goldstein N, Herzog AR (1992) Epidemiology of bladder emptying symptoms in elderly men. J Urol 148:1817–1821
Ekman P (1989) BPH epidemiology and risk factors. Prostate [Suppl] 2:23–31
Eldrup E, Lindholm J, Winkel P (1987) Plasma sex hormones and ischaemic heart disease. Clin Biochem 20:105–112
Farnsworth WE, Slaunwhite WR, Sharma M et al (1981) Interactions of prolactin and testosterone in the human prostate. Urol Res 9:79–88
Fletcher RH, Fletcher SW, Wagner EH (1988) Clinical epidemiology. The essentials, 2nd edn. Williams and Wilkins, Baltimore
Frea B, Annoscia S, Santa G, Lozzi C, Carmignani G (1987) Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study. Urol Res 15:311–314
Garraway WM, Collins GN, Lee RJ (1991) High prevalence of benign prostatic hypertrophy in the community. Lancet 338:469–471
Ghose RR, Harindra V (1989) Unrecognised high pressure chronic retention of urine presenting with systemic arterial hypertension. BMJ 298:1626–1628
Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121:78–90
Gordon GG, Altman K, Southren AL, Rubin E, Lieber CS (1976) Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men. N Engl J Med 295:793–797
Gover M (1923) A statistical study of the etiology of benign hypertrophy of the prostate gland. John Hopkins Hosp Rep 21:231–295
Greenwald P, Kirmass V, Polan AK, Dick VS (1974) Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53:335–340
Guess HA (1992) Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 14:131–153
Huggins C, Stevens R (1940) The effect of castration on benign hypertrophy of the prostate in man. J Urol 43:705–714
Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate [Suppl] 2:33–50
Jakobsen H, Torp PS, Juul N, Hald T (1988) The long term influence of vasectomy on prostatic volume and morphology in man. Prostate 13:57–67
Jones DA, George NJR, O’Reilly PH, Barnard RJ (1987) Reversible hypertension associated with unrecognised high-pressure chronic retention of urine. Lancet 1:1052–1054
Kambal A (1977) Prostatic obstruction in Sudan. Br J Urol 49:139–141
Lee C, Jesik C (1983) Effects of castration, estrogen, and androgen administration. In: Hinman FH Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 229–334
Lissoos I (1973) Simple prostatic hyperplasia in the Bantu. S Afr Med J 47:389–391
Lytton B (1983) Interracial incidence of benign prostatic hypertrophy. In: Hinman FH Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 22–26
Lytton B, Emery JM, Harvard BM (1968) The incidence of benign prostatic hypertrophy. J Urol 99:639–645
Matzin H, Soloway MS (1993) Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 22:277–290
McNeal JE (1978) Origin and evolution of benign prostatic enlargement. Invest Urol 15:340–345
McPherson K, Wennberg JE, Hovind OB, Clifford P (1982) Small-area variations in the use of common surgical procedures: an international comparison of New England, England and Norway. N Engl J Med 307:1310–1314
Meyhoff HH, Hald T (1979) Are doctors able to assess prostatic size? Scand J Urol Nephrol 13:229
Meyhoff HH, Ingeman L, Nordling J (1981) Accuracy in preoperative estimation of prostatic size: a comparative evaluation of rectal palpation, intavenous pyelography, urethral closure pressure profile recording and cystourethroscopy. Scand J Urol Nephrol 15:45–51
Moore RA (1943) Benign hypertrophy of the prostate. A morphological study. J Urol 50:680–710
Morrison AS (1978) Prostatic hypertrophy in Greater Boston. J Chronic Dis 31:357–362
Morrison AS (1990) Smoking and prostatic hypertrophy. In: Wald N, Baron J (eds) Smoking and hormone related disorders. Oxford University Press, Oxford, pp 183–196
Morrison AS (1992) Risk factors for prostatic hypertrophy. Am J Epidemiol 135:974–980
Movsas S (1966) Prostatic obstruction in the african and asiatic. Br J Surg 53:538–543
Nomura AMY, Kolonel LN (1991) Prostate cancer: a current perspective. Epidemiol Rev 13:200–227
Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC (1991) The influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 145:405–409
Peters CA, Walsh PC (1987) The effects of nafarelin acetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 317:599–604
Pierrepoint CG (1975) Does hormone transfer along the vas deferentia contribute of the control of prostatic function and could it be a factor in the etiology of prostatic hyperplasia? In: Goland M (ed) Normal and abnormal growth of the prostate. Thomas, Springfield, pp 517–529
Randall A (1931) Surgical pathology of prostatic obstructions. Williams and Wilkins, Baltimore, pp 11–16
Richardson IM (1964) Prostatic hyperplasia and social class. Br J Prev Soc Med 18:157–162
Roehrborn CG (1993) Objective and subjective response criteria to diagnose benign prostatic hyperplasia. Eur Urol 24[Suppl 1]:2–11
Ross RK, Bernstein L, Paganini-Hill A, Henderson BE (1990) Effects of cigarette smoking on hormone-related disease in a southern California retirement community. In: Wald N, Baron J (eds) Smoking and hormone related disorders. Oxford University Press, Oxford, pp 32–54
Seitter WR, Barrett-Connor E (1992) Cigarette smoking, obesity, and benign prostatic hypertrophy: a population-based study. Am J Epidemiol 135:500–503
Shaaraway M, Mahmoud KZ (1982) Endocrine profile and semen characteristics in male smokers. Fertil Steril 38:255–257
Sidney S (1987) Vasectomy and the risk of prostatic cancer and benign prostatic hypertrophy. J Urol 138:795–797
Sidney S, Quesenberry C Jr, Sadler MC, Lydick EG, Guess HA, Cattolica EV (1991a) Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 38[Suppl 1]:13–19
Sidney S, Quesenberry C Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV (1991b) Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 134:825–829
Steele R, Lees REM, Kraus AS, Rao C (1971) Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis 24:29–37
Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M (1991) Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-1987. A population-based study. Urology 38[Suppl l]:32–42
Stumpf HH, Wilens SL (1953) Inhibitory effects of portal cirrhosis of liver on prostatic enlargement. Arch Intern Med 91:304–309
Syms AJ, Harper ME, Griffiths K (1985) The effect of prolactin on human BPH epithelial cell proliferation. Prostate 6:145–153
Teboul F, Ecochard R, Colin C, Matillon Y, Berger N, Urol College of Lyon (1991) Descriptive analysis of a series of operations for prostatic adenomas in inhabitants of Lyon, France, in 1988. Eur Urol 20[Suppl 2]:18–21
Turner-Warwick RT, Whiteside CG, Arnold EP et al (1973) A urodynamic view of prostatic obsturction and the results of prostatectomy. Br J Urol 45:631–639
Walsh PC (1992) Benign prostatic hyperplasia. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds) Campbell’s urology, 6th edn. Saunders, Philadelphia, pp 1009–1025
Walsh PC, Wilson JD (1976) The induction of prostatic hypertrophy in the dog with and— rostanediol. J Clin Invest 57:1093–1097
Watanabe H, Date S, Ohe H (1980) A survey of 3000 examinations by transrectal ultrasonography. Prostate 1:271–278
Wennberg JE, Barnes BA, Zubkoff M (1982) Professional uncertainty and the problem of supplier induced demand. Soc Sci Med 16:811–824
Wennberg JE, Mulley AG Jr, Hanley D et al (1988) An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA 259:3027–3030
WHO (1986) World health statistics annual. WHO, Geneva
Wilson JD (1980) The pathogenesis of benign prostatic hyperplasia. Am J Med 68:745–756
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shepherd, S. (1995). Aetiological Factors in Benign Prostatic Hyperplasia. In: Garraway, M. (eds) Epidemiology of Prostate Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78826-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-78826-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78828-4
Online ISBN: 978-3-642-78826-0
eBook Packages: Springer Book Archive